# Exaggerated IFN-I Response in Long COVID PBMCs Following Exposure to Viral Mimics

**Authors:** Bart Humer, Julia C. Berentschot, Cornelia G. van Helden-Meeuwsen, L. Martine Bek, Maaike de Bie, Tobias M. Defesche, Chantal A. Boly, Manon Drost, Merel E. Hellemons, Willem A. Dik, Marjan A. Versnel

PMC · DOI: 10.1007/s10875-025-01969-w · Journal of Clinical Immunology · 2025-12-10

## TL;DR

This study shows that immune cells from long COVID patients overreact to viral mimics, suggesting a possible role of hyperactive immune responses in the condition.

## Contribution

The study identifies a hyperresponsive IFN-I pathway in long COVID patients compared to healthy controls using viral mimics.

## Key findings

- PBMCs from long COVID patients showed increased IFN-I bioactivity after stimulation with cGAS and RIG-I agonists.
- Unsupervised clustering revealed distinct immune response patterns between long COVID patients and healthy controls.
- A moderate correlation was found between RIG-I stimulation and fatigue severity in long COVID patients.

## Abstract

Long COVID (LC) is a long-term debilitating disease of which the exact pathophysiology is unknown. A dysregulated immune response resulting in hyperresponsive immune cells is hypothesized as a key mechanism in the development of LC. Several studies suggest that acute infections can leave lasting epigenetic changes, which result in heightened immune reactivity. Upon stimulation, these primed immune cells may exhibit exaggerated responses. This form of epigenetic memory can contribute to altered immune dynamics, particularly in response to induction of type I Interferons (IFN-I) pathway activation using a viral mimic. Therefore, we investigated if LC patients exhibit a hyperresponsive response towards viral mimics in comparison with healthy controls (HC).

PBMCs of two distinct LC cohorts, characterized by a different disease course and duration, were collected and transfected using Lyovec with the cGAS and RIG-I agonists G3-YSD and 3p-RNA followed by measurement of IFN-I bioactivity with a reporter cell line.

Transfection of PBMCs of LC patients with the cGAS and RIG-I agonists resulted in increased IFN-I bioactivity in comparison with HC. Unsupervised hierarchical clustering revealed two distinct clusters, each predominantly composed of either patients or HC. In addition, a moderate correlation between RIG-I stimulation with 3p-RNA and fatigue severity scores was found.

These data show a hyperresponsive phenotype of immune cells of LC patients upon stimulation with viral mimics. The current availability of biologicals and small molecule inhibitors that interfere with aberrant IFN-I pathway activation underscores the importance of pursuing future investigations into this phenomenon.

The online version contains supplementary material available at 10.1007/s10875-025-01969-w.

## Linked entities

- **Proteins:** CGAS (cyclic GMP-AMP synthase), RIGI (RNA sensor RIG-I)

## Full-text entities

- **Genes:** RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}
- **Diseases:** term debilitating disease (MESH:D000088562), LC (MESH:D000094024), fatigue (MESH:D005221), infections (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12795936/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12795936/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12795936/full.md

---
Source: https://tomesphere.com/paper/PMC12795936